FDA Inspection 1264019 — Front Pharmaceutical PLC

Front Pharmaceutical PLC — FEI 3011575652

The FDA completed an inspection of Front Pharmaceutical PLC on Mar 7, 2025 in Xuancheng. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Xuancheng (China)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
360321 CFR 211.160(b)Scientifically sound laboratory controls